Transforming growth factor β1 represses proximal tubular cell microRNA-192 expression through decreased hepatocyte nuclear factor DNA binding.

miR (microRNA)-192 plays key roles in renal pathological and physiological responses, by repressing targets including Zeb1, Zeb2 and Wnk1. In the present study, we have assessed the regulation of miR-192 expression. We found that TGF-β1 (transforming growth factor β1) down-regulates miR-192 and miR-194, co-transcribed in the shared precursor pri-miR (primary miR transcript)-192/194. Luciferase reporter analysis showed constitutive promoter activity within nucleotides +21 to -223. We identified HNF (hepatocyte nuclear factor) and p53 binding sites within this region that were required for constitutive promoter activity, which was decreased by TGF-β1 through an Alk5-dependent mechanism. TGF-β1 treatment decreased HNF binding to the miR-194-2/192 promoter, whereas knockdown of HNF-1 inhibited mature miR-192 and miR-194 expression. miR-192, miR-194 and HNF expression were restricted to a defined subset of human tissues including kidney, small intestine, colon and liver. Our results from the present study identify co-ordinated regulation of miR-192 and miR-194, with binding of HNF and p53 transcription factors necessary for activation of transcription, and TGF-β1-mediated repression through decreased HNF binding to its cognate promoter element.

[1]  Seongjoon Koo,et al.  Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. , 2004, Nucleic acids research.

[2]  J. Iacomini,et al.  Identification of a microRNA signature of renal ischemia reperfusion injury , 2010, Proceedings of the National Academy of Sciences.

[3]  Jianxing He,et al.  MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells , 2011, Nucleic acids research.

[4]  H. Aburatani,et al.  Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4α (HNF4α) isoforms in human and rats , 2003, Nuclear receptor.

[5]  H. Aburatani,et al.  Cell Type-specific Target Selection by Combinatorial Binding of Smad2/3 Proteins and Hepatocyte Nuclear Factor 4α in HepG2 Cells , 2011, The Journal of Biological Chemistry.

[6]  Aimee L Jackson,et al.  Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. , 2008, Cancer research.

[7]  E. Bandrés,et al.  miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation , 2010, Molecular Cancer Therapeutics.

[8]  G. Goodall,et al.  E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β , 2010, Diabetes.

[9]  A. Hattersley,et al.  Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  Mitsuo Kato,et al.  A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. , 2011, Kidney international.

[11]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[12]  Huey-Jen Lin,et al.  Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. , 2010, Cancer cell.

[13]  L. Wakefield,et al.  Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor. , 2002, The American journal of pathology.

[14]  Mingyu Liang,et al.  MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. , 2008, Genome research.

[15]  E. Li,et al.  Serum and urinary free microRNA level in patients with systemic lupus erythematosus , 2011, Lupus.

[16]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[17]  R. Zager,et al.  HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. , 1994, Kidney international.

[18]  P. Igarashi,et al.  Roles of HNF-1beta in kidney development and congenital cystic diseases. , 2005, Kidney international.

[19]  Mitsuo Kato,et al.  Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.

[20]  E. Abraham,et al.  Identification of a microRNA signature in renal fibrosis: role of miR-21. , 2011, American journal of physiology. Renal physiology.

[21]  Kimihiro Hino,et al.  Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. , 2008, RNA.

[22]  John J Rossi,et al.  MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors , 2007, Proceedings of the National Academy of Sciences.

[23]  Robert H. Jenkins,et al.  Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[24]  Gang Wang,et al.  Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. , 2010, American journal of hypertension.

[25]  Xin Zhang,et al.  p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. , 2008, Cancer research.

[26]  N. Farman,et al.  Regulation of WNK1 expression by miR-192 and aldosterone. , 2010, Journal of the American Society of Nephrology : JASN.

[27]  Remco Nagel,et al.  The miRNA‐192/194 cluster regulates the Period gene family and the circadian clock , 2009, The FEBS journal.

[28]  A. Phillips,et al.  The Human Hyaluronan Synthase 2 (HAS2) Gene and Its Natural Antisense RNA Exhibit Coordinated Expression in the Renal Proximal Tubular Epithelial Cell♦ , 2011, The Journal of Biological Chemistry.

[29]  Robert H. Jenkins,et al.  A Conserved Stem Loop Motif in the 5′Untranslated Region Regulates Transforming Growth Factor-β1 Translation , 2010, PloS one.

[30]  Bo Song,et al.  miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit , 2008, Clinical Cancer Research.

[31]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[32]  B. Cullen Transcription and processing of human microRNA precursors. , 2004, Molecular cell.

[33]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[34]  J. Long,et al.  MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy* , 2011, The Journal of Biological Chemistry.

[35]  Gang Wang,et al.  Intrarenal expression of microRNAs in patients with IgA nephropathy , 2010, Laboratory Investigation.

[36]  S. Lowe,et al.  miR-19 is a key oncogenic component of mir-17-92. , 2009, Genes & development.

[37]  J. Groffen,et al.  SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains , 2007, Nucleic acids research.

[38]  Hui Zhou,et al.  Liver‐enriched transcription factors regulate MicroRNA‐122 that targets CUTL1 during liver development , 2010, Hepatology.

[39]  K. Bhatt,et al.  microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. , 2011, American journal of physiology. Renal physiology.

[40]  L. Adorini,et al.  Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model , 2010, Diabetes.

[41]  Z. Saifudeen,et al.  Transcriptional control of terminal nephron differentiation. , 2008, American journal of physiology. Renal physiology.

[42]  Xiao-ming Meng,et al.  miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[43]  J. Mendell miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.